| Year |
Citation |
Score |
| 2015 |
de Waal L, Lewis TA, Rees MG, Tsherniak A, Wu X, Choi PS, Gechijian L, Hartigan C, Faloon PW, Hickey MJ, Tolliday N, Carr SA, Clemons PA, Munoz B, Wagner BK, et al. Identification of cancer-cytotoxic modulators of PDE3A by predictive chemogenomics. Nature Chemical Biology. PMID 26656089 DOI: 10.1038/Nchembio.1984 |
0.335 |
|
| 2015 |
Dockendorff C, Faloon PW, Yu M, Youngsaye W, Penman M, Nieland TJ, Nag PP, Lewis TA, Pu J, Bennion M, Negri J, Paterson C, Lam G, Dandapani S, Perez JR, et al. Indolinyl-Thiazole Based Inhibitors of Scavenger Receptor-BI (SR-BI)-Mediated Lipid Transport. Acs Medicinal Chemistry Letters. 6: 375-380. PMID 26478787 DOI: 10.1021/Ml500154Q |
0.303 |
|
| 2015 |
Dockendorff C, Faloon PW, Germain A, Yu M, Youngsaye W, Nag PP, Bennion M, Penman M, Nieland TJ, Dandapani S, Perez JR, Munoz B, Palmer MA, Schreiber SL, Krieger M. Discovery of bisamide-heterocycles as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake. Bioorganic & Medicinal Chemistry Letters. 25: 2594-8. PMID 25958245 DOI: 10.1016/J.Bmcl.2015.03.074 |
0.33 |
|
| 2015 |
Dockendorff C, Faloon PW, Pu J, Yu M, Johnston S, Bennion M, Penman M, Nieland TJ, Dandapani S, Perez JR, Munoz B, Palmer MA, Schreiber SL, Krieger M. Benzo-fused lactams from a diversity-oriented synthesis (DOS) library as inhibitors of scavenger receptor BI (SR-BI)-mediated lipid uptake. Bioorganic & Medicinal Chemistry Letters. 25: 2100-5. PMID 25900219 DOI: 10.1016/J.Bmcl.2015.03.073 |
0.333 |
|
| 2015 |
Waal Ld, Lewis TA, Rees MG, Tsherniak A, Wu X, Choi PS, Gechijian L, Hartigan C, Faloon PW, Hickey MJ, Tolliday N, Carr SA, Clemons PA, Munoz B, Wagner BK, et al. Abstract C136: Identification of selective cancer cytotoxic modulators of phosphodiesterase 3a by predictive chemogenomics Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C136 |
0.318 |
|
| 2014 |
Waal LMd, Lewis TA, Gechijian L, Tsherniak A, Youngsaye W, Rees M, Mikse O, Hickey M, Faloon P, Tolliday N, Koehler A, Schenone M, Wong K, Shamji A, Munoz B, et al. Abstract 4596: An integrated genomic characterization of the target of a small molecule identifies a novel cancer dependency Cancer Research. 74: 4596-4596. DOI: 10.1158/1538-7445.Am2014-4596 |
0.359 |
|
| 2011 |
Chou DH, Duvall JR, Gerard B, Liu H, Pandya BA, Suh BC, Forbeck EM, Faloon P, Wagner BK, Marcaurelle LA. Synthesis of a novel suppressor of beta-cell apoptosis via diversity-oriented synthesis. Acs Medicinal Chemistry Letters. 2: 698-702. PMID 21927648 DOI: 10.1021/Ml200120M |
0.332 |
|
| 2007 |
Wang C, Faloon PW, Tan Z, Lv Y, Zhang P, Ge Y, Deng H, Xiong JW. Mouse lysocardiolipin acyltransferase controls the development of hematopoietic and endothelial lineages during in vitro embryonic stem-cell differentiation. Blood. 110: 3601-9. PMID 17675553 DOI: 10.1182/Blood-2007-04-086827 |
0.418 |
|
| 2007 |
Liu J, Fraser SD, Faloon PW, Rollins EL, Vom Berg J, Starovic-Subota O, Laliberte AL, Chen JN, Serluca FC, Childs SJ. A betaPix Pak2a signaling pathway regulates cerebral vascular stability in zebrafish. Proceedings of the National Academy of Sciences of the United States of America. 104: 13990-5. PMID 17573532 DOI: 10.1073/Pnas.0700825104 |
0.337 |
|
| 2003 |
Ema M, Faloon P, Zhang WJ, Hirashima M, Reid T, Stanford WL, Orkin S, Choi K, Rossant J. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse Genes and Development. 17: 380-393. PMID 12569129 DOI: 10.1101/Gad.1049803 |
0.502 |
|
| 2002 |
Arentson E, Faloon P, Seo J, Moon E, Studts JM, Fremont DH, Choi K. Oncogenic potential of the DNA replication licensing protein CDT1. Oncogene. 21: 1150-8. PMID 11850834 DOI: 10.1038/Sj.Onc.1205175 |
0.444 |
|
| 1999 |
Schuh AC, Faloon P, Hu Q, Bhimani M, Choi K. In vitro hematopoietic and endothelial potential of flk-1−/− embryonic stem cells and embryos Proceedings of the National Academy of Sciences of the United States of America. 96: 2159-2164. PMID 10051611 DOI: 10.1073/Pnas.96.5.2159 |
0.479 |
|
| Show low-probability matches. |